bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation

TJ McDonnell, N Deane, FM Platt, G Nunez, U Jaeger… - Cell, 1989 - cell.com
TJ McDonnell, N Deane, FM Platt, G Nunez, U Jaeger, JP McKearn, SJ Korsmeyer
Cell, 1989cell.com
Human follicular 6 cell lymphomas possess at (14; 18) interchromosomal translocation that
juxtaposes the putative proto-oncogene bcl-2 with the immunoglobulin (lg) heavy chain
locus. We generated minigene constructs representing the bcl-2-lg fusion gene found at this
chromosomal breakpoint. These constructs were placed into the germ line of mice to assess
the effects of the t (14; 18) during development. The transgene demonstrates a lymphoid
pattern of expression and uniformly results in an expanded folllcular center cell population …
Summary
Human follicular 6 cell lymphomas possess at (14; 18) interchromosomal translocation that juxtaposes the putative proto-oncogene bcl-2 with the immunoglobulin (lg) heavy chain locus. We generated minigene constructs representing the bcl-2-lg fusion gene found at this chromosomal breakpoint. These constructs were placed into the germ line of mice to assess the effects of the t (14; 18) during development. The transgene demonstrates a lymphoid pattern of expression and uniformly results in an expanded folllcular center cell population. Hyperplastic splenic follicles coalesce to form massive regions of splenic white pulp. Mice over 15 weeks of age demonstrate regional lymphadenopathy with abnormal cellular infiltrates. The expanded lymphoid compartment is composed predominantly of polyclonal B220-positive, IgMllgD-positive B cells. Provocatively, the bcl-2-lg transgene confers a survival advantage to a population of mature B cells assessed in vitro. bcl-2-lg transgenic mice document a prospective role for the t (14; 18) in B cell growth and the pathogenesis of follicular lymphoma.
cell.com